Cain Labs

Transforming outcomes

At the Gordon and Mary Cain Pediatric Neurology Research Foundation Laboratories, our team of world-class investigators find innovative new treatments for epilepsy and other devastating brain diseases.

In partnership with

Leveraging cutting-edge epilepsy research to save lives

Leveraging cutting-edge epilepsy research to save lives

"The Cain Labs were founded to alleviate the terrible suffering of childhood epilepsies. Over the past 30 years, we've made significant progress, and today we are expanding our vision to aspire to treat neuropsychiatric and cognitive comorbidities, as well." — Dr. Sameer Sheth, Director 

Latest news and discoveries

Novel gene therapy improves outcomes for animal models with STXBP1 disorder

In this pioneering pre-clinical study, Dr. Mingshan Xue's lab has found a promising gene therapy candidate for STXBP1 disorder, which causes catastrophic childhood epilepsies.

Translating our discovery pipeline into effective new treatments

By implementing cutting-edge neuromodulatory techniques that target underlying brain circuits, Cain Labs investigators are translating basic scientific research into new treatments for epilepsy and other related brain diseases — including neuropsychiatric and mood disorders.

Help fund a better future

Your generous donations make our research possible. Give today, and you’ll help us continue our search for answers and give children with devastating neurological conditions the promise of a brighter tomorrow.